New innovations in dementia research: from a new assessment of premorbid functioning to a review of the evidence base for post-diagnostic Cognitive Rehabilitation
Item Status
Embargo End Date
Date
Authors
Phillips, Joanne
Abstract
BACKGROUND:
Dementia is a national priority for Scotland, and as such, fast and accurate diagnosis plus
responsive and well-evidenced interventions post-diagnosis are key. Accurately estimating
an individual’s level of premorbid functioning can be a crucial part of establishing that
cognitive decline has taken place, enabling clinicians to be more confident and accurate in
their diagnosis. Measures that assess premorbid ability should be able to 1) capture current
ability in healthy controls and 2) resist the effects of cognitive decline when used in
individuals with dementia. At the post-diagnostic stage, there is a growing evidence base for
non-pharmacological, tailored interventions for individuals with dementia. However, the
evidence base is limited, particularly so for Cognitive Rehabilitation.
OBJECTIVES:
An empirical study was conducted in order to assess whether a newly developed measure
that aims to capture lifelong cognitive reserve (the brain’s ability to withstand pathological
change), the Cognitive Reserve Index Questionnaire (CRIq), can capture premorbid ability.
Three research questions were addressed; 1) does the CRIq capture current ability in
healthy controls? 2) is it resistant to cognitive decline when used with a patient group with
dementia? and 3) how does the CRIq compare to a traditional measure of premorbid ability,
the NART (National Adult Reading Test)? Another focus of development and innovation in
dementia research is that of post-diagnostic interventions. A systematic review was
therefore conducted in order to evaluate the effectiveness of Cognitive Rehabilitation for
mild-moderate dementia (Alzheimer disease or mixed dementia) in relation to cognitive and
functional outcomes. Due to the limited number of RCTs in this field precluding a clear
understanding of the evidence base, the additional contribution of non-RCTs was also
evaluated.
METHOD:
For the empirical study N=20 healthy older controls and N=13 patients with dementia were
recruited. In order to appropriately address the three research questions both groups were
assessed using the NART, the CRIq and the MOCA (Montreal Cognitive Assessment). In
addition, the control group were assessed on a measure of current ability, the WAIS-IV
Perceptual Reasoning Index. For the systematic review of Cognitive Rehabilitation the CDCIG
Specialised Register, ALOIS, was searched in order to identify relevant studies. In addition,
previous reviews were searched to identify studies excluded on the basis that they were not
an RCT.
RESULTS:
Results for the empirical study show both CRIq and NART were strongly correlated to
current ability (performance on WAIS-IV PRI) in controls, although both significantly overestimated
ability. CRIq performance was not affected by the presence of dementia whereas
NART predicted premorbid ability was. CRIq and NART showed a different pattern of results
between controls and patients, indicating that CRIq may more resistant to the effects of
cognitive decline. Ten studies were identified for the systematic review; five RCT and five
non-RCT. Study quality was assessed using a well-validated quality assessment tool, and
indicated large variability. Eight of the ten studies reported a positive effect of Cognitive
Rehabilitation. However, several studies were of poor quality and included aspects of other
approaches in their intervention (e.g. Cognitive Training, Cognitive-Behaviour Therapy).
CONCLUSIONS:
The empirical study found that CRIq over-estimated current ability in controls, but was
resistant to cognitive decline in patients. The over-estimation of current ability may be
accounted for by the CRIq being normed on an Italian population, thus not reflecting UK
cultural norms (e.g. for length of schooling). When the NART and the CRIq were directly
compared, the two measures were found to be related, but yet produced significantly
different estimates of premorbid ability. This suggests that they may capture different facets
of premorbid functioning, with the NART being primarily a verbal performance-based
measure, and the CRIq capturing aspects of global cognitive functioning. Clinical implications
include the potential utility of the CRIq for patients with language impairment. However the
study conclusions are limited by a low N, and therefore have restricted generalisability. In
the systematic review, the literature was exhaustively searched and evidence was found for
the effectiveness of Cognitive Rehabilitation for mild-moderate Alzheimer disease and
mixed dementia. Methodological limitations of the included studies are discussed, and
clinical implications are identified. Both the empirical study and the systematic review
highlight the need for greater research and development of methods by which dementia
care is supported; through more effective methods of diagnosis, to a better evidence base
for post-diagnostic interventions.
This item appears in the following Collection(s)

